Literature DB >> 10460273

Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states.

P Honor1, P M Menning, S D Rogers, M L Nichols, A I Basbaum, J M Besson, P W Mantyh.   

Abstract

Inflammatory pain involves the sensitization of both primary afferent and spinal cord neurons. To explore the neurochemical changes that contribute to inflammatory pain, we have examined the expression and ligand-induced internalization of the substance P receptor (SPR) in the spinal cord in acute, short-term, and long-term inflammatory pain states. These inflammatory models included unilateral injection of formalin (8-60 min), carrageenan (3 hr), and complete Freund's adjuvant (CFA; 3 d) into the rat hindpaw as well as adjuvant-induced polyarthritis (21 d). In acute inflammatory pain there is ongoing release of substance P (SP) as measured by SPR internalization in lamina I neurons at both 8 and 60 min after formalin injection. Although there is no tonic release of SP in short-term inflammatory pain, at 3 hr after carrageenan injection, SP is released in response to both noxious and non-noxious somatosensory stimulation with SPR internalization being observed in neurons located in both laminae I and III-IV. In long-term inflammatory pain models (CFA and polyarthritis) the same pattern of SP release and SPR activation occurs as is observed in short-term inflammation with the addition that there is a significant upregulation of the SPR in lamina I neurons. These results suggest that SPR internalization might serve as a marker of the contribution of ongoing primary afferent input in acute and persistent pain states. These stereotypical neurochemical changes suggest that there are unique neurochemical signatures for acute, short-term, and long-term inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460273      PMCID: PMC6782496     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  67 in total

Review 1.  The formalin test: an evaluation of the method.

Authors:  Arne Tjølsen; Odd-Geir Berge; Steinar Hunskaar; Jan Henrik Rosland; Kjell Hole
Journal:  Pain       Date:  1992-10       Impact factor: 6.961

2.  The formalin-induced expression of tachykinin peptide and neurokinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration.

Authors:  K E McCarson; J E Krause
Journal:  Neuroscience       Date:  1995-02       Impact factor: 3.590

3.  Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat.

Authors:  M J Millan; A Członkowski; B Morris; C Stein; R Arendt; A Huber; V Höllt; A Herz
Journal:  Pain       Date:  1988-12       Impact factor: 6.961

Review 4.  Inflammatory mediators of pain.

Authors:  A Dray
Journal:  Br J Anaesth       Date:  1995-08       Impact factor: 9.166

5.  Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocaine.

Authors:  C Abbadie; B K Taylor; M A Peterson; A I Basbaum
Journal:  Pain       Date:  1997-01       Impact factor: 6.961

Review 6.  The induction of pain: an integrative review.

Authors:  M J Millan
Journal:  Prog Neurobiol       Date:  1999-01       Impact factor: 11.685

7.  Quantitative analysis of substance P and calcitonin gene-related peptide immunohistochemical staining in the dorsal horn of neuropathic MK-801-treated rats.

Authors:  C J Garrison; P M Dougherty; S M Carlton
Journal:  Brain Res       Date:  1993-04-02       Impact factor: 3.252

8.  Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin.

Authors:  P Honoré; J Buritova; J M Besson
Journal:  Eur J Pharmacol       Date:  1995-01-16       Impact factor: 4.432

9.  Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain.

Authors:  C Abbadie; J L Brown; P W Mantyh; A I Basbaum
Journal:  Neuroscience       Date:  1996-01       Impact factor: 3.590

10.  Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord.

Authors:  M J Cumberbatch; B A Chizh; P M Headley
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more
  51 in total

Review 1.  Mechanism of cancer pain.

Authors:  Brian L Schmidt; Darryl T Hamamoto; Donald A Simone; George L Wilcox
Journal:  Mol Interv       Date:  2010-06

2.  Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations.

Authors:  Louis P Vera-Portocarrero; Ying Lu; Karin N Westlund
Journal:  Anesthesiology       Date:  2003-02       Impact factor: 7.892

3.  Src family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors.

Authors:  Guohua Zhang; Wenling Chen; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

4.  Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.

Authors:  M J Schwei; P Honore; S D Rogers; J L Salak-Johnson; M P Finke; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

5.  Kainate receptors are primarily postsynaptic to SP-containing axon terminals in the trigeminal dorsal horn.

Authors:  Deborah M Hegarty; Jennifer L Mitchell; Kristin C Swanson; Sue A Aicher
Journal:  Brain Res       Date:  2007-10-04       Impact factor: 3.252

6.  Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury.

Authors:  Ruizhong Wang; Tamara King; Michael H Ossipov; Anthony J Rossomando; Todd W Vanderah; Pamela Harvey; Peter Cariani; Eric Frank; Dinah W Y Sah; Frank Porreca
Journal:  Nat Neurosci       Date:  2008-03-23       Impact factor: 24.884

7.  Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce mu-opioid receptor internalization in the presence of peptidase inhibitors.

Authors:  Lijun Lao; Bingbing Song; Wenling Chen; Juan Carlos G Marvizón
Journal:  Brain Res       Date:  2008-01-03       Impact factor: 3.252

8.  μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.

Authors:  W Chen; J A McRoberts; J C G Marvizón
Journal:  Neuroscience       Date:  2014-02-26       Impact factor: 3.590

9.  Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.

Authors:  Juan Carlos Marvizon; Wenling Chen; Weisi Fu; Bradley K Taylor
Journal:  Neuropharmacology       Date:  2019-08-02       Impact factor: 5.250

10.  Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by mu-opioid receptor internalization.

Authors:  W Chen; J C G Marvizón
Journal:  Neuroscience       Date:  2009-03-17       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.